Compounds > cyclosporine

cyclosporine and HIV

cyclosporine has been researched along with HIV in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (50.00)18.2507
2000's5 (35.71)29.6817
2010's2 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bart, PA; Bellutti Enders, F; Cavassini, M; Cellerai, C; Faouzi, M; Harari, A; Miconnet, I; Ohmiti, K; Pantaleo, G; Perreau, M; Rozot, V; Savoye, AL; Viganò, S1
Ballarin, R; Cautero, N; Cocchi, S; Codeluppi, M; D'Amico, G; De Ruvo, N; Di Benedetto, F; Gerunda, GE; Guaraldi, G; Guerrini, GP; Iemmolo, RM; Mimmo, A; Montalti, R; Rompianesi, G; Serra, V; Smerieri, N; Spaggiari, M; Tarantino, G1
Grill, SM; Leelawong, M; Oswald-Richter, K; Unutmaz, D1
Aliberti, J; Andersen, JF; Caspar, P; Golding, H; King, LR; Sher, A; Yarovinsky, F1
Bolton, EM; Bradley, JA; Carmichael, A; Lever, AM; Murfitt, CR; Pettigrew, GJ; Zhao, J1
Deeks, SG; Hunt, PW1
High, KP1
Bonham, CA; Thomson, AW1
Pauza, CD; Streblow, DN1
Bartz, SR; Hohenwalter, E; Hu, MK; Malkovsky, M; Rich, DH1
Borvak, J; Chou, CS; Ramilo, O; Rosenwirth, B; Van Dyke, G; Vitetta, ES1
Clumeck, N1
Gilden, D1
Antinori, A; Chiusolo, P; Cingolani, A; De Luca, A; Laurenti, L; Leone, G; Ortona, L; Piccirillo, N; Rutella, S; Sica, S; Sorà, F1

Reviews

4 review(s) available for cyclosporine and HIV

ArticleYear
Immune-based therapy for HIV infection: are acute and chronic HIV infection different diseases?
    The Journal of infectious diseases, 2006, Dec-15, Volume: 194, Issue:12

    Topics: Cyclosporine; HIV; HIV Infections; Humans; Lymphocyte Activation; T-Lymphocytes; Treatment Outcome

2006
The antimicrobial activities of cyclosporine, FK506, and rapamycin.
    Transplantation, 1994, Jun-27, Volume: 57, Issue:12

    Topics: Animals; Anti-Infective Agents; Antiviral Agents; B-Lymphocytes; Bacterial Infections; Cyclosporine; HIV; Humans; Immunosuppressive Agents; Parasitic Diseases; Polyenes; Sirolimus; T-Lymphocytes; Tacrolimus; Virus Diseases

1994
Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection.
    Advances in experimental medicine and biology, 1995, Volume: 374

    Topics: Animals; Apoptosis; Clinical Trials as Topic; Cyclosporine; HIV; HIV Infections; Humans; Immunosuppressive Agents; Lymphocyte Activation; Tacrolimus

1995
Therapeutic approaches to HIV infection based on virus structure and the host pathogen interaction.
    Current topics in microbiology and immunology, 1995, Volume: 202

    Topics: Antiviral Agents; Cyclosporine; Drug Design; Drug Resistance, Microbial; Gene Products, rev; Genetic Variation; HIV; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Immunologic Factors; rev Gene Products, Human Immunodeficiency Virus; RNA-Directed DNA Polymerase; Virion

1995

Other Studies

10 other study(ies) available for cyclosporine and HIV

ArticleYear
Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells.
    PLoS pathogens, 2013, Volume: 9, Issue:7

    Topics: Anti-Retroviral Agents; Antibodies, Viral; Antibody Affinity; CD8-Positive T-Lymphocytes; Chronic Disease; Cohort Studies; Cross-Sectional Studies; Cyclosporine; Disease Progression; Epitope Mapping; HIV; HIV Infections; Humans; Immunity, Cellular; Immunosuppressive Agents; Longitudinal Studies; Receptors, Antigen, T-Cell; Up-Regulation; Viremia; Virus Replication

2013
University of Modena experience in HIV-positive patients undergoing liver transplantation.
    Transplantation proceedings, 2011, Volume: 43, Issue:4

    Topics: Adult; Antiretroviral Therapy, Highly Active; Carcinoma, Hepatocellular; CD4 Lymphocyte Count; Cyclosporine; Drug Substitution; End Stage Liver Disease; Female; Graft Rejection; Graft Survival; Hepatitis C, Chronic; HIV; HIV Infections; Hospitals, University; Humans; Immunosuppressive Agents; Italy; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Severity of Illness Index; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome; Viral Load

2011
HIV infection of primary human T cells is determined by tunable thresholds of T cell activation.
    European journal of immunology, 2004, Volume: 34, Issue:6

    Topics: CD4-Positive T-Lymphocytes; Cell Division; Cyclosporine; DNA-Binding Proteins; HIV; HIV Infections; Humans; Kinetics; Lymphocyte Activation; NFATC Transcription Factors; Nuclear Proteins; Receptors, Antigen, T-Cell; Receptors, Interleukin-2; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Signal Transduction; Sirolimus; Tacrolimus; Transcription Factors; Virus Replication

2004
Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii.
    The Journal of biological chemistry, 2004, Dec-17, Volume: 279, Issue:51

    Topics: Amino Acid Sequence; Animals; Antiviral Agents; Binding, Competitive; CCR5 Receptor Antagonists; Cyclophilins; Cyclosporine; DNA Mutational Analysis; Dose-Response Relationship, Drug; HIV; Interleukin-12; Kinetics; Ligands; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Plasmids; Plasmodium falciparum; Protein Binding; Protein Conformation; Recombinant Proteins; Spleen; Toxoplasma; Vaccinia virus

2004
Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection.
    Gene therapy, 2005, Volume: 12, Issue:20

    Topics: Animals; Cyclosporine; Genetic Therapy; Genetic Vectors; Graft Rejection; Heart Transplantation; HIV; Immunosuppressive Agents; Interleukin-10; Lymphocyte Activation; Lymphocytes; Male; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Transduction, Genetic; Transplantation, Homologous; Treatment Outcome

2005
Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Jun-06, Volume: 92, Issue:12

    Topics: Antiviral Agents; Cell Line; Cyclosporine; Cyclosporins; Drug Design; HIV; Humans; Interleukin-2; Lymphocyte Activation; Lymphocytes; Models, Molecular; Virus Replication

1995
The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus.
    The Journal of infectious diseases, 1996, Volume: 174, Issue:4

    Topics: Antiviral Agents; Cell Division; Coculture Techniques; Cyclosporine; HIV; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Receptors, Interleukin-2; Tacrolimus

1996
[Human immunodeficiency virus infection: physiopathological approach to specific therapeutic strategies].
    Revue medicale de Bruxelles, 1996, Volume: 17, Issue:4

    Topics: CD4 Lymphocyte Count; CD4-CD8 Ratio; Cyclosporine; HIV; HIV Infections; Humans; Immunosuppressive Agents; Interleukin-2; Tumor Necrosis Factor-alpha; Virus Replication

1996
Sandoz axes cyclosporine research.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:12

    Topics: Animals; Biological Availability; Cyclosporine; HIV; Humans; Immunosuppressive Agents

1995
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia.
    Experimental hematology, 2002, Volume: 30, Issue:3

    Topics: Adult; Antigens, CD34; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hepatitis C; HIV; HIV Infections; Humans; Leukemia, Myeloid, Acute; Remission Induction; RNA, Viral; Transplantation, Homologous; Viremia

2002